ÖZET
Amaç:
Bu çalışmada; sigara içenlerde huzursuz bacaklar sendromu (HBS) görülme sıklığının belirlenmesi ve bağımlılık derecesi ile ilişkisinin araştırılması amaçlandı.
Yöntemler:
Bu prospektif çalışma, tanımlayıcı ve tek merkezli bir çalışma olarak tasarlandı. Çalışma etik kurul onayı alındıktan sonra; 01/03/2017 ile 01/07/2017 tarihleri arasında herhangi bir nedenle üçüncü basamak bir hastaneye başvuran sigara içicileri ile yapıldı. Tüm olgulara Uluslararası Huzursuz Bacaklar Sendromu Çalışma Grubu (IRLSSG) tarafından geliştirilen huzursuz bacaklar tanı formu uygulandı. Beş kriterin tamamına sahip olanlara HBS tanısı konuldu. Katılımcıların nikotin bağımlıklarını değerlendirmek için Fagerström Nikotin Bağımlılık Testi (FNBT) uygulandı. Anlamlılık p<0,05 düzeyinde kabul edildi.
Bulgular:
Çalışmaya dahil edilen 3011 kişinin çoğu erkek (%52,3; n=1,579) idi. FNBT’ye göre katılımcıların %68,4’ü (n=2,059) orta ve yüksek derecede bağımlı idi. Toplamda tüm katılımcıların %9,8’inde (n=296) HBS saptandı. Düşük derecede bağımlılığı olan grupta HBS varlığı %6,9 (n=66) iken orta-yüksek derecede bağımlılığı olan grupta %11,2 (n=230) bulundu ve aradaki bu farklılık istatistiksel olarak anlamlı bulundu (p=0,02).
Sonuç:
Bu çalışmada, sigara içenlerde HBS görülme oranı genel popülasyona göre yüksek bulunmuş olup bağımlılık düzeyi arttıkça HBS görülme sıklığının arttığı saptandı.
References
1
Garcia-Borreguero D, Williams A-M. An update on restless legs (Willis-Ekbomdisease): clinical features, pathogenezis and treatment. Curr Opin Neurol 2014;27:493-501.
2
Mungan S, Ozcan M, Orhan G, Titiz A, Arli B, Koseoglu S, et al. Clinical and polysomnographic features of patients with Restless Legs Syndrome. J Pak Med Assoc 2016;66:568-73.
3
Willis T. The London Practice of Physic. Bassett and Crook, London. 1685.
4
Ekbom KA. Restless legs: a clinical study. Acta Med Scand Suppl 1945;158:1-123.
5
Yilmaz K, Kilicaslan A, Aydin N, Kor D. Prevalence and correlates of restless legs syndrome in adolescents. Dev Med Child Neurol 2011;53:40-7.
6
Demir AU, Ardic S, Firat H, Karadeniz D, Aksu M, Ucar ZZ, et al. Prevalence of sleep disorders in the Turkish adult population epidemiology of sleep study. Sleep and Biological Rhytmes 2015;13:298-308.
7
Altunayoglu Cakmak V, Koc B, Nuhoglu I, Topbas M, Ucuncu SY, Deger O, et al. Prevalence of restless legs syndrome in Trabzon in the northeast Black Sea Region of Turkey: co-morbidities, socioeconomic factors and biochemical parameters. Neurol Res 2015;37:751-62.
8
Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria - history, rationale, description, and significance. Sleep Med 2014;15:860-73.
9
Sayin S, Atilla FD. Overlooked clinical presentation of iron deficiency; Restless Leg Syndrome. Ankara Med J. 2019;19-3.
10
Tasdemir M, Erdogan H, Börü UT, Dilaver E, Kumas A. Epidemiology of restless legs syndrome in Turkish adults on the western Black Sea coast of Turkey: A door to-door study in a rural area. Sleep Medicine 2010;11:82-6.
11
Manconi M, Ferri R, Zucconi M, Clemens S, Rundo F, Oldani A, et al. Effects of acute dopamine-agonist treatment in restless legs syndrome on heart rate variability during sleep. Sleep Med 2011;12:47-55.
12
Yalınay Dikmen P. Restless legs syndrome treatments in adults: practice guideline summary of American Academy of Neurology. Journal of Turkish Sleep Medicine 2017;4:59-64.
13
World health statistics overview 2019: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2019 (WHO/DAD/2019.1). Licence: CC BY-NC-SA 3.0 IGO.
14
WHO global report on trends in prevalence of tobacco smoking 2000-2025, second edition. Geneva: World Health Organization;2018.
15
Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137-41.
16
Sevim S, Dogu O, Kaleagasi H, Aral M, Metin O, Camdeviren H. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey, J Neurol Neurosurg Psychiatry 2004;75:226-30.
17
Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and risk of RLS in the general population. Arch İntern Med 2004;164:196-202.
18
Dündar F. Huzursuz bacaklar sendromu ve sigara, Ankara Üniversitesi/Tıp Fakültesi / Nöroloji Anabilim Dalı, 443683, 2016.
19
Didriksen M, Rigas AS, Allen RP, Burchell BJ, Di Angelantonio E, Nielsen MH, et al. Prevalence of restless legs syndrome and associated factors in an otherwise healthy population: results from the Danish Blood Donor Study. Sleep Med 2017;36:55-61.
20
Park YM, Lee HJ, Kang SG, Choi HS, Choi JE, Cho JH, et al. Prevalence of idio-pathic and secondary restless legs syndrome in Korean women. Gen Hosp Psychiatry 2010;32:164-8.
21
Hadjigeorgiou GM, Stefanidis I, Dardiotis E, Aggellakis K, Sakkas GK, Xiromerisiou G, et al. Low RLS prevalence and awareness in central Greece: an epidemiological survey. Eur J Neurol. 2007;14:1275-80.
22
Benediktsdottir B, Janson C, Lindberg E, Arnardóttir ES, Olafsson I, Cook E, et al. Prevalence of restless legs syndrome among adults in Iceland and Sweden: lung function, comorbidity, ferritin, biomarkers and quality of life. Sleep Med 2010;11:1043-8.
23
Cho YW, Shin WC, Yun CH, Hong SB, Kim JH, Allen RP, et al. Epidemiology of restless legs syndrome in Korean adults. Sleep 2008;31:219-23.
24
Phillips B, Hening W, Britz P, Mannino D. Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest 2006;129:76-80.
25
Winkelmann J, Muller-Myhsok B, Wittchen HU, Hock B, Prager M, Pfi ster H, et al. Complex seregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol 2002;52:297-302.
26
Haba-Rubio J, Marti-Soler H, Marques-Vidal P, Tobback N, Andries D, Preisig M, et al. Prevalence and determinants of periodic limb movements in the general population. Ann Neurol 2016;79:464-74.
27
Vogl FD, Pichler I, Adel S, Pinggera GK, Bracco S, De Grandi A, et al. Restless legs syndrome: epidemiological and clinicogenetic study in a South Tyrolean population isolate. Mov Disord. 2006;21:1189-95.
28
Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ, et al. Restless Legs syndrome prevalance and impact: REST General Population Study. Arch Intern Med 2005;165:1286-92.
29
Sevim S, Dogu O, Camdeviren H, Bugdayci R, Sasmaz T, Kaleagasi H, et al. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology 2003;61:1562-9.
30
Liu Y, Liu G, Li L, Yang J, Ma S. Evaluation of cardiovascular risk factors and restless legs syndrome in women and men: A preliminary population-based study in China. J Clin Sleep Med 2018;14:445-50.
31
Batool-Anwar S, Li Y, De Vito K, Malhotra A, Winkelman J, Gao X. Lifestyle factors and risk of restless legs syndrome: prospective cohort study. J Clin Sleep Med 2016;12:187-94.
32
Winkelman JW, Shahar E, Sharief I, Gottlieb DJ. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology 2008;70:35-42.
33
Ceylan M, Aygül R, Yalçın A. Investigation of restless leg syndrome prevalence and assosiated sociodemographic features in province of Erzurum. J Contemp Med 2019;9:48-54.
34
Aydın Ş, Özdemir C, Sökücü SN.The Relationship Between Restless Legs Syndrome and Cardiovascular Risk Factors. Journal of Turkish Sleep Medicine 2019;1:29-36.
35
Oksenberg A. Alleviation of severe restless legs syndrome (RLS) symptoms by cigarette smoking. J Clin Sleep Med. 2010;6:489-90.
